Chemistry:Vutiglabridin

From HandWiki
Short description: Chemical compound
Vutiglabridin
Vutiglabridin.svg
Legal status
Legal status
  • Investigational
Identifiers
CAS Number
PubChem CID
UNII
Chemical and physical data
FormulaC22H26O4
Molar mass354.446 g·mol−1
3D model (JSmol)

Vutiglabridin (HSG4112) is an experimental anti-obesity drug that is a synthetic structural analog of glabridin.[1][2][3]

References

  1. Hyeon, Jooseung; Lee, Jihan; Kim, Eunju; Lee, Hyeong Min; Kim, Kwang Pyo; Shin, Jaejin; Park, Hyung Soon; Lee, Yun-Il et al. (October 2023). "Vutiglabridin exerts anti-ageing effects in aged mice through alleviating age-related metabolic dysfunctions". Experimental Gerontology 181: 112269. doi:10.1016/j.exger.2023.112269. PMID 37567452. 
  2. Na, Joo Young; Yoon, Deok Yong; Yoo, Hyounggyoon; Lee, SeungHwan; Yu, Kyung‐Sang; Jang, In‐Jin; Yoo, Sang‐Ku; Kim, Youngah et al. (November 2022). "Safety, tolerability, pharmacokinetic, and pharmacodynamic characteristics of vutiglabridin: A first‐in‐class, first‐in‐human study" (in en). Clinical and Translational Science 15 (11): 2744–2757. doi:10.1111/cts.13401. ISSN 1752-8054. PMID 36176051. PMC 9652434. https://doi.org/10.1111/cts.13401. 
  3. Choi, Leo Sungwong; Jo, In Geun; Kang, Ku Suk; Im, Jeong Ho; Kim, Jiyoung; Kim, Jinyoung; Chung, Jin Wook; Yoo, Sang-Ku (January 2021). "Discovery and preclinical efficacy of HSG4112, a synthetic structural analog of glabridin, for the treatment of obesity" (in en). International Journal of Obesity 45 (1): 130–142. doi:10.1038/s41366-020-00686-1. ISSN 1476-5497. PMID 32943760.